CN114984293B - Wound antibacterial healing-promoting dressing and preparation method thereof - Google Patents
Wound antibacterial healing-promoting dressing and preparation method thereof Download PDFInfo
- Publication number
- CN114984293B CN114984293B CN202210758005.5A CN202210758005A CN114984293B CN 114984293 B CN114984293 B CN 114984293B CN 202210758005 A CN202210758005 A CN 202210758005A CN 114984293 B CN114984293 B CN 114984293B
- Authority
- CN
- China
- Prior art keywords
- preparing
- wound
- spinning
- secretion
- mixed solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000000844 anti-bacterial effect Effects 0.000 title claims abstract description 40
- 238000002360 preparation method Methods 0.000 title claims abstract description 21
- 239000000835 fiber Substances 0.000 claims abstract description 74
- 239000000843 powder Substances 0.000 claims abstract description 58
- 238000009987 spinning Methods 0.000 claims abstract description 51
- 230000028327 secretion Effects 0.000 claims abstract description 45
- 239000003814 drug Substances 0.000 claims abstract description 35
- JWYVGKFDLWWQJX-UHFFFAOYSA-N 1-ethenylazepan-2-one Chemical compound C=CN1CCCCCC1=O JWYVGKFDLWWQJX-UHFFFAOYSA-N 0.000 claims abstract description 26
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 26
- 229910021389 graphene Inorganic materials 0.000 claims abstract description 26
- 229940079593 drug Drugs 0.000 claims abstract description 22
- 238000005507 spraying Methods 0.000 claims abstract description 15
- 239000000017 hydrogel Substances 0.000 claims abstract description 14
- 239000011159 matrix material Substances 0.000 claims abstract description 14
- 239000011259 mixed solution Substances 0.000 claims description 52
- 239000000243 solution Substances 0.000 claims description 30
- 238000000227 grinding Methods 0.000 claims description 26
- 238000003851 corona treatment Methods 0.000 claims description 20
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 18
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 14
- 238000002156 mixing Methods 0.000 claims description 14
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 13
- 239000004677 Nylon Substances 0.000 claims description 12
- 229920001778 nylon Polymers 0.000 claims description 12
- 238000003756 stirring Methods 0.000 claims description 12
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 11
- 241001071795 Gentiana Species 0.000 claims description 11
- 229910021538 borax Inorganic materials 0.000 claims description 11
- 238000000265 homogenisation Methods 0.000 claims description 11
- 238000002074 melt spinning Methods 0.000 claims description 11
- 239000000661 sodium alginate Substances 0.000 claims description 11
- 235000010413 sodium alginate Nutrition 0.000 claims description 11
- 229940005550 sodium alginate Drugs 0.000 claims description 11
- 235000010339 sodium tetraborate Nutrition 0.000 claims description 11
- 239000004328 sodium tetraborate Substances 0.000 claims description 11
- 239000007788 liquid Substances 0.000 claims description 10
- 239000011324 bead Substances 0.000 claims description 9
- 229910052757 nitrogen Inorganic materials 0.000 claims description 9
- 238000010298 pulverizing process Methods 0.000 claims description 9
- 235000000177 Indigofera tinctoria Nutrition 0.000 claims description 3
- 230000003385 bacteriostatic effect Effects 0.000 claims description 3
- 229940097275 indigo Drugs 0.000 claims description 3
- COHYTHOBJLSHDF-UHFFFAOYSA-N indigo powder Natural products N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 claims description 3
- 206010052428 Wound Diseases 0.000 abstract description 46
- 208000027418 Wounds and injury Diseases 0.000 abstract description 46
- 206010048629 Wound secretion Diseases 0.000 abstract description 5
- 239000000203 mixture Substances 0.000 abstract description 4
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 238000012545 processing Methods 0.000 abstract description 2
- 208000012886 Vertigo Diseases 0.000 description 45
- 230000000052 comparative effect Effects 0.000 description 18
- 230000035876 healing Effects 0.000 description 9
- QQILFGKZUJYXGS-UHFFFAOYSA-N Indigo dye Chemical compound C1=CC=C2C(=O)C(C3=C(C4=CC=CC=C4N3)O)=NC2=C1 QQILFGKZUJYXGS-UHFFFAOYSA-N 0.000 description 8
- 230000001737 promoting effect Effects 0.000 description 6
- 239000002994 raw material Substances 0.000 description 6
- 230000029663 wound healing Effects 0.000 description 6
- 241000700159 Rattus Species 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 238000000338 in vitro Methods 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 229920001661 Chitosan Polymers 0.000 description 3
- 108010022355 Fibroins Proteins 0.000 description 3
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 3
- 241000191967 Staphylococcus aureus Species 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 239000005313 bioactive glass Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000005498 polishing Methods 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 2
- 241000193996 Streptococcus pyogenes Species 0.000 description 2
- 208000002847 Surgical Wound Diseases 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 235000012907 honey Nutrition 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 235000021419 vinegar Nutrition 0.000 description 2
- 239000000052 vinegar Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 241000239290 Araneae Species 0.000 description 1
- 241000208202 Linaceae Species 0.000 description 1
- 235000004431 Linum usitatissimum Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000031737 Tissue Adhesions Diseases 0.000 description 1
- 206010048038 Wound infection Diseases 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- RNFNDJAIBTYOQL-UHFFFAOYSA-N chloral hydrate Chemical compound OC(O)C(Cl)(Cl)Cl RNFNDJAIBTYOQL-UHFFFAOYSA-N 0.000 description 1
- 229960002327 chloral hydrate Drugs 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000003195 fascia Anatomy 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000006916 nutrient agar Substances 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000013341 scale-up Methods 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/18—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing inorganic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/24—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/28—Polysaccharides or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/40—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing ingredients of undetermined constitution or reaction products thereof, e.g. plant or animal extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/30—Compounds of undetermined constitution extracted from natural sources, e.g. Aloe Vera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/602—Type of release, e.g. controlled, sustained, slow
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Materials Engineering (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Botany (AREA)
- Zoology (AREA)
- Materials For Medical Uses (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The application discloses a wound antibacterial healing-promoting dressing and a preparation method thereof, belonging to the technical field of medical dressing processing, and comprising the following steps: s1, preparing medicinal powder; s2, preparing drug-loaded fibers; s3, preparing secretion absorbing fibers; s4, spinning; s5, spraying. The application breaks through the conventional dressing manufacturing method, blends the medicine-carrying part and the secretion absorbing part into different fibers, and adopts a warp-weft spinning mode to vertically and horizontally distribute the secretion absorbing part and the medicine-carrying antibacterial healing-promoting part, so that the prepared dressing has mechanical strength, can effectively avoid the negative influence of wound secretion on antibacterial healing-promoting, and can sterilize and heal wounds while sucking the secretion. Finally, spraying hydrogel with poly-N-vinyl caprolactam (PNVCL) and Graphene Oxide (GO) as matrix materials on one side of the blended gauze, mainly for leading out wound secretion.
Description
Technical Field
The application belongs to the technical field of medical dressing processing, and particularly relates to a wound antibacterial healing-promoting dressing and a preparation method thereof.
Background
Methods and means of wound treatment have undergone a number of changes over time. With the development of the age, people have come to use materials obtained from nature such as leaves, honey, spider web, bark, vinegar, wine, etc. for wound treatment. About 1600 years before the metric element, people soaked flax strips in oil and attached plasters, which were used as wound dressings. By 400 years before the male, hippocrates et al used honey mixed wine or vinegar to clean wounds and also used water or wine-boiled wool as a medical bandage, with the development of scientific research, the advent of antibacterial methods and antibiotics marked an important advance in modern medicine in the 19 th century; later in the 20 th century, modern wound dressings were born. Nowadays, the dressing can not only better cover the wound surface, but also promote the healing and recovery of the wound. The dressing mainly plays a role in absorbing secretion and healing wounds, but when the wound is healed, the released secretion can play a role in the healing, and even can cause the proliferation of mixed bacteria at the wound, so that the wound is healed all the time.
The application number 201610745185.8 discloses a wound antibacterial healing-promoting dressing, and the effective components of the dressing are paste comprising silk fibroin raw materials, bioactive glass raw materials, chitosan raw materials and polyvinyl alcohol raw materials which are uniformly mixed. The method for preparing the dressing comprises the steps of firstly uniformly mixing a silk fibroin solution and bioactive glass powder, then adding a chitosan solution and a polyvinyl alcohol solution, stirring to form a mixed solution, repeatedly freezing and thawing to obtain a wound dressing material difficult to heal, and controlling the water vapor permeability, the water absorption, the water retention and the antibacterial property of the obtained dressing by adjusting the proportion among the silk fibroin solution, the chitosan solution, the polyvinyl alcohol solution and the bioactive glass serving as raw materials to enable the dressing to meet the requirements of promoting wound healing; the preparation method has the advantages of mild reaction conditions, simple process and low raw material cost, and is suitable for industrial scale-up production. Although the dressing obtained by the application method has the water vapor permeability, water absorption, water retention and antibacterial performance, and can meet the requirements of wound healing, the negative influence caused by secretion at the wound cannot be avoided.
Disclosure of Invention
The application aims at solving the existing problems and provides a wound antibacterial healing-promoting dressing and a preparation method thereof.
The application is realized by the following technical scheme:
a preparation method of a wound antibacterial healing-promoting dressing comprises the following steps:
s1, preparing medicinal powder:
s101, placing natural indigo, borax and gentian together in a bead mill according to a weight ratio of 1:7-10:10-12, adding liquid nitrogen for grinding, and taking out powder A for standby after finishing;
s102, placing the powder A obtained in the step S101 into a corona discharge instrument for corona treatment, and then placing into a superfine pulverizer for pulverization treatment to obtain medicinal powder;
s2, preparing drug-loaded fibers:
s201, uniformly stirring and mixing a polyvinyl alcohol solution and a sodium alginate solution according to the weight ratio of 3-4:1 under the constant temperature condition to obtain a mixed solution A for standby;
s202, adding the medicinal powder obtained in the step S1 into the mixed solution A, and then placing the mixed solution A into a micro-jet high-pressure homogenizer for high-pressure homogenization treatment to obtain a mixed solution B for later use;
s203, spinning the mixed solution B obtained in the step S202 to obtain a drug-loaded fiber for later use;
s3, preparing secretion absorbing fibers:
adding poly-N-vinyl caprolactam (PNVCL) and Graphene Oxide (GO) into nylon melt spinning to prepare a secretion absorbing fiber for later use;
s4, spinning:
spinning the obtained medicine carrying fiber and secretion absorbing fiber in a warp-weft spinning mode to obtain blended gauze for standby;
s5, spraying:
one side of the blended gauze is sprayed with hydrogel taking poly-N-vinyl caprolactam (PNVCL) and Graphene Oxide (GO) as matrix materials.
Further, the polishing rate is controlled to 300 to 400rpm during the polishing treatment in step S101, and the polishing treatment time is controlled to 30 to 40rpm.
Further, the operating voltage is controlled to be 10-12 kV during the corona treatment in the step S102, and the time of the corona treatment is 30-40S.
Further, the constant temperature in step S201 is 60 to 70 ℃.
Further, the working pressure is controlled to be 70-80 MPa during the high-pressure homogenizing treatment in the step S202, and the homogenizing treatment time is 40-60S.
Compared with the prior art, the application has the following advantages:
1. the application provides a preparation method of wound antibacterial and healing promoting dressing, which is characterized in that natural indigo, borax and gentian are specially treated to prepare medicinal powder, and then the medicinal powder is added into the preparation of medicine-carrying fibers, so that the medicinal powder can be well fused with the fibers and can be slowly released in the use of the dressing, and the antibacterial and healing promoting effect is achieved.
2. According to the application, poly-N-vinyl caprolactam (PNVCL) and Graphene Oxide (GO) are added into nylon spinning to prepare the secretion absorbing fiber, and the fiber can well absorb wound secretion in the use of the dressing.
3. The application breaks through the conventional dressing manufacturing method, blends the medicine-carrying part and the secretion absorbing part into different fibers, and adopts a warp-weft spinning mode to vertically and horizontally distribute the secretion absorbing part and the medicine-carrying antibacterial healing-promoting part, so that the prepared dressing has mechanical strength, can effectively avoid the negative influence of wound secretion on antibacterial healing-promoting, and can sterilize and heal wounds while sucking the secretion. Finally, spraying hydrogel with poly-N-vinyl caprolactam (PNVCL) and Graphene Oxide (GO) as matrix materials on one side of the blended gauze, mainly for leading out wound secretion.
Detailed Description
Example 1:
a preparation method of a wound antibacterial healing-promoting dressing comprises the following steps:
s1, preparing medicinal powder:
s101, placing indigo naturalis, borax and gentian together in a bead mill according to a weight ratio of 1:7:10, adding liquid nitrogen for grinding, controlling the grinding speed to be 300rpm, and taking out powder A for standby after grinding treatment is performed at 30 rpm;
s102, placing the powder A obtained in the step S101 into a corona discharge instrument for corona treatment, controlling the working voltage to be 10kV, controlling the corona treatment time to be 30S, and then placing the powder A into a superfine pulverizer for pulverizing treatment to obtain medicinal powder;
s2, preparing drug-loaded fibers:
s201, uniformly stirring and mixing a polyvinyl alcohol solution and a sodium alginate solution according to a weight ratio of 3:1 at a constant temperature of 60 ℃ to obtain a mixed solution A for standby;
s202, adding the medicinal powder obtained in the step S1 into the mixed solution A, then placing the mixed solution A into a micro-jet high-pressure homogenizer for high-pressure homogenization treatment, controlling the working pressure to be 70MPa, and homogenizing for 40 seconds to obtain a mixed solution B for later use;
s203, spinning the mixed solution B obtained in the step S202 to obtain a drug-loaded fiber for later use;
s3, preparing secretion absorbing fibers:
adding poly-N-vinyl caprolactam (PNVCL) and Graphene Oxide (GO) into nylon melt spinning to prepare a secretion absorbing fiber for later use;
s4, spinning:
spinning the obtained medicine carrying fiber and secretion absorbing fiber in a warp-weft spinning mode to obtain blended gauze for standby;
s5, spraying:
one side of the blended gauze is sprayed with hydrogel taking poly-N-vinyl caprolactam (PNVCL) and Graphene Oxide (GO) as matrix materials.
Example 2:
a preparation method of a wound antibacterial healing-promoting dressing comprises the following steps:
s1, preparing medicinal powder:
s101, placing indigo naturalis, borax and gentian together in a bead mill according to a weight ratio of 1:8.5:11, adding liquid nitrogen for grinding, controlling the grinding speed to be 350rpm, and taking out powder A for standby after grinding treatment is carried out at 35 rpm;
s102, placing the powder A obtained in the step S101 into a corona discharge instrument for corona treatment, controlling the working voltage to be 11kV, controlling the corona treatment time to be 35S, and then placing the powder A into a superfine pulverizer for pulverizing treatment to obtain medicinal powder;
s2, preparing drug-loaded fibers:
s201, uniformly stirring and mixing a polyvinyl alcohol solution and a sodium alginate solution according to the weight ratio of 3.5:1 at the constant temperature of 65 ℃ to obtain a mixed solution A for standby;
s202, adding the medicinal powder obtained in the step S1 into the mixed solution A, then placing the mixed solution A into a micro-jet high-pressure homogenizer for high-pressure homogenization treatment, controlling the working pressure to be 75MPa, and homogenizing for 50S to obtain a mixed solution B for later use;
s203, spinning the mixed solution B obtained in the step S202 to obtain a drug-loaded fiber for later use;
s3, preparing secretion absorbing fibers:
adding poly-N-vinyl caprolactam (PNVCL) and Graphene Oxide (GO) into nylon melt spinning to prepare a secretion absorbing fiber for later use;
s4, spinning:
spinning the obtained medicine carrying fiber and secretion absorbing fiber in a warp-weft spinning mode to obtain blended gauze for standby;
s5, spraying:
one side of the blended gauze is sprayed with hydrogel taking poly-N-vinyl caprolactam (PNVCL) and Graphene Oxide (GO) as matrix materials.
Example 3:
a preparation method of a wound antibacterial healing-promoting dressing comprises the following steps:
s1, preparing medicinal powder:
s101, placing indigo naturalis, borax and gentian together in a bead mill according to a weight ratio of 1:10:12, adding liquid nitrogen for grinding, controlling the grinding speed to be 400rpm, and taking out powder A for standby after grinding treatment at 40 rpm;
s102, placing the powder A obtained in the step S101 into a corona discharge instrument for corona treatment, controlling the working voltage to be 12kV, controlling the corona treatment time to be 40S, and then placing the powder A into a superfine pulverizer for pulverizing treatment to obtain medicinal powder;
s2, preparing drug-loaded fibers:
s201, uniformly stirring and mixing a polyvinyl alcohol solution and a sodium alginate solution according to a weight ratio of 4:1 at a constant temperature of 70 ℃ to obtain a mixed solution A for standby;
s202, adding the medicinal powder obtained in the step S1 into the mixed solution A, then placing the mixed solution A into a micro-jet high-pressure homogenizer for high-pressure homogenization treatment, controlling the working pressure to be 80MPa, and homogenizing for 60 seconds to obtain a mixed solution B for later use;
s203, spinning the mixed solution B obtained in the step S202 to obtain a drug-loaded fiber for later use;
s3, preparing secretion absorbing fibers:
adding poly-N-vinyl caprolactam (PNVCL) and Graphene Oxide (GO) into nylon melt spinning to prepare a secretion absorbing fiber for later use;
s4, spinning:
spinning the obtained medicine carrying fiber and secretion absorbing fiber in a warp-weft spinning mode to obtain blended gauze for standby;
s5, spraying:
one side of the blended gauze is sprayed with hydrogel taking poly-N-vinyl caprolactam (PNVCL) and Graphene Oxide (GO) as matrix materials.
Comparative example 1:
a preparation method of a wound antibacterial healing-promoting dressing comprises the following steps:
s1, preparing medicinal powder:
uniformly mixing indigo naturalis, borax and gentian according to a weight ratio of 1:8.5:11, placing the mixture in a corona discharge instrument for corona treatment, controlling the working voltage to be 11kV, controlling the time of the corona treatment to be 35s, and then placing the mixture in an ultrafine pulverizer for pulverizing to obtain medicinal powder;
s2, preparing drug-loaded fibers:
s201, uniformly stirring and mixing a polyvinyl alcohol solution and a sodium alginate solution according to the weight ratio of 3.5:1 at the constant temperature of 65 ℃ to obtain a mixed solution A for standby;
s202, adding the medicinal powder obtained in the step S1 into the mixed solution A, then placing the mixed solution A into a micro-jet high-pressure homogenizer for high-pressure homogenization treatment, controlling the working pressure to be 75MPa, and homogenizing for 50S to obtain a mixed solution B for later use;
s203, spinning the mixed solution B obtained in the step S202 to obtain a drug-loaded fiber for later use;
s3, preparing secretion absorbing fibers:
adding poly-N-vinyl caprolactam (PNVCL) and Graphene Oxide (GO) into nylon melt spinning to prepare a secretion absorbing fiber for later use;
s4, spinning:
spinning the obtained medicine carrying fiber and secretion absorbing fiber in a warp-weft spinning mode to obtain blended gauze for standby;
s5, spraying:
one side of the blended gauze is sprayed with hydrogel taking poly-N-vinyl caprolactam (PNVCL) and Graphene Oxide (GO) as matrix materials.
Comparative example 2:
a preparation method of a wound antibacterial healing-promoting dressing comprises the following steps:
s1, preparing medicinal powder:
s101, placing indigo naturalis, borax and gentian together in a bead mill according to a weight ratio of 1:8.5:11, adding liquid nitrogen for grinding, controlling the grinding speed to be 350rpm, and taking out powder A for standby after grinding treatment is carried out at 35 rpm;
s102, placing the powder A obtained in the step S101 into a superfine pulverizer for pulverizing treatment to obtain medicinal powder;
s2, preparing drug-loaded fibers:
s201, uniformly stirring and mixing a polyvinyl alcohol solution and a sodium alginate solution according to the weight ratio of 3.5:1 at the constant temperature of 65 ℃ to obtain a mixed solution A for standby;
s202, adding the medicinal powder obtained in the step S1 into the mixed solution A, then placing the mixed solution A into a micro-jet high-pressure homogenizer for high-pressure homogenization treatment, controlling the working pressure to be 75MPa, and homogenizing for 50S to obtain a mixed solution B for later use;
s203, spinning the mixed solution B obtained in the step S202 to obtain a drug-loaded fiber for later use;
s3, preparing secretion absorbing fibers:
adding poly-N-vinyl caprolactam (PNVCL) and Graphene Oxide (GO) into nylon melt spinning to prepare a secretion absorbing fiber for later use;
s4, spinning:
spinning the obtained medicine carrying fiber and secretion absorbing fiber in a warp-weft spinning mode to obtain blended gauze for standby;
s5, spraying:
one side of the blended gauze is sprayed with hydrogel taking poly-N-vinyl caprolactam (PNVCL) and Graphene Oxide (GO) as matrix materials.
Comparative example 3:
a preparation method of a wound antibacterial healing-promoting dressing comprises the following steps:
s1, preparing medicinal powder:
s101, placing indigo naturalis, borax and gentian together in a bead mill according to a weight ratio of 1:8.5:11, adding liquid nitrogen for grinding, controlling the grinding speed to be 350rpm, and taking out powder A for standby after grinding treatment is carried out at 35 rpm;
s102, placing the powder A obtained in the step S101 into a corona discharge instrument for corona treatment, controlling the working voltage to be 11kV, and carrying out corona treatment for 35S to obtain medicinal powder;
s2, preparing drug-loaded fibers:
s201, uniformly stirring and mixing a polyvinyl alcohol solution and a sodium alginate solution according to the weight ratio of 3.5:1 at the constant temperature of 65 ℃ to obtain a mixed solution A for standby;
s202, adding the medicinal powder obtained in the step S1 into the mixed solution A, then placing the mixed solution A into a micro-jet high-pressure homogenizer for high-pressure homogenization treatment, controlling the working pressure to be 75MPa, and homogenizing for 50S to obtain a mixed solution B for later use;
s203, spinning the mixed solution B obtained in the step S202 to obtain a drug-loaded fiber for later use;
s3, preparing secretion absorbing fibers:
adding poly-N-vinyl caprolactam (PNVCL) and Graphene Oxide (GO) into nylon melt spinning to prepare a secretion absorbing fiber for later use;
s4, spinning:
spinning the obtained medicine carrying fiber and secretion absorbing fiber in a warp-weft spinning mode to obtain blended gauze for standby;
s5, spraying:
one side of the blended gauze is sprayed with hydrogel taking poly-N-vinyl caprolactam (PNVCL) and Graphene Oxide (GO) as matrix materials.
Comparative example 4:
a preparation method of a wound antibacterial healing-promoting dressing comprises the following steps:
s1, preparing medicinal powder:
s101, placing indigo naturalis, borax and gentian together in a bead mill according to a weight ratio of 1:8.5:11, adding liquid nitrogen for grinding, controlling the grinding speed to be 350rpm, and taking out powder A for standby after grinding treatment is carried out at 35 rpm;
s102, placing the powder A obtained in the step S101 into a corona discharge instrument for corona treatment, controlling the working voltage to be 11kV, controlling the corona treatment time to be 35S, and then placing the powder A into a superfine pulverizer for pulverizing treatment to obtain medicinal powder;
s2, preparing drug-loaded fibers:
s201, uniformly stirring and mixing a polyvinyl alcohol solution and a sodium alginate solution according to the weight ratio of 3.5:1 at the constant temperature of 65 ℃ to obtain a mixed solution A for standby;
s202, adding the medicinal powder obtained in the step S1 into the mixed solution A, and uniformly mixing to obtain a mixed solution B for standby;
s203, spinning the mixed solution B obtained in the step S202 to obtain a drug-loaded fiber for later use;
s3, preparing secretion absorbing fibers:
adding poly-N-vinyl caprolactam (PNVCL) and Graphene Oxide (GO) into nylon melt spinning to prepare a secretion absorbing fiber for later use;
s4, spinning:
spinning the obtained medicine carrying fiber and secretion absorbing fiber in a warp-weft spinning mode to obtain blended gauze for standby;
s5, spraying:
one side of the blended gauze is sprayed with hydrogel taking poly-N-vinyl caprolactam (PNVCL) and Graphene Oxide (GO) as matrix materials.
Comparative example 5:
a preparation method of a wound antibacterial healing-promoting dressing comprises the following steps:
s1, preparing medicine carrying fibers:
s101, uniformly stirring and mixing a polyvinyl alcohol solution and a sodium alginate solution according to a weight ratio of 3.5:1 at a constant temperature of 65 ℃ to obtain a mixed solution A for standby;
s102, carrying out spinning treatment on the mixed solution A obtained in the step S201 to obtain a medicine-carrying fiber for standby;
s2, preparing secretion absorbing fibers:
adding poly-N-vinyl caprolactam (PNVCL) and Graphene Oxide (GO) into nylon melt spinning to prepare a secretion absorbing fiber for later use;
s3, spinning:
spinning the obtained medicine carrying fiber and secretion absorbing fiber in a warp-weft spinning mode to obtain blended gauze for standby;
s4, spraying:
one side of the blended gauze is sprayed with hydrogel taking poly-N-vinyl caprolactam (PNVCL) and Graphene Oxide (GO) as matrix materials.
Comparative example 6:
a preparation method of a wound antibacterial healing-promoting dressing comprises the following steps:
s1, preparing medicinal powder:
s101, placing indigo naturalis, borax and gentian together in a bead mill according to a weight ratio of 1:8.5:11, adding liquid nitrogen for grinding, controlling the grinding speed to be 350rpm, and taking out powder A for standby after grinding treatment is carried out at 35 rpm;
s102, placing the powder A obtained in the step S101 into a corona discharge instrument for corona treatment, controlling the working voltage to be 11kV, controlling the corona treatment time to be 35S, and then placing the powder A into a superfine pulverizer for pulverizing treatment to obtain medicinal powder;
s2, preparing drug-loaded fibers:
s201, uniformly stirring and mixing a polyvinyl alcohol solution and a sodium alginate solution according to the weight ratio of 3.5:1 at the constant temperature of 65 ℃ to obtain a mixed solution A for standby;
s202, adding the medicinal powder obtained in the step S1 into the mixed solution A, then placing the mixed solution A into a micro-jet high-pressure homogenizer for high-pressure homogenization treatment, controlling the working pressure to be 75MPa, and homogenizing for 50S to obtain a mixed solution B for later use;
s203, spinning the mixed solution B obtained in the step S202 to obtain a drug-loaded fiber for later use;
s4, spinning:
spinning the obtained medicine carrying fiber in a warp-weft spinning mode to obtain gauze for standby;
s5, spraying:
one side of the gauze is sprayed with hydrogel taking poly-N-vinyl caprolactam (PNVCL) and Graphene Oxide (GO) as matrix materials.
Comparative example 7:
a preparation method of a wound antibacterial healing-promoting dressing comprises the following steps:
s1, preparing secretion absorbing fibers:
adding poly-N-vinyl caprolactam (PNVCL) and Graphene Oxide (GO) into nylon melt spinning to prepare a secretion absorbing fiber for later use;
s2, spinning:
spinning the secretion absorbing fiber in a warp and weft spinning mode to obtain gauze for standby;
s3, spraying:
one side of the gauze is sprayed with hydrogel taking poly-N-vinyl caprolactam (PNVCL) and Graphene Oxide (GO) as matrix materials.
Control group
The application number is: 201610745185.8A wound antibacterial and healing promoting dressing and its preparation method are disclosed.
In order to compare the technical effects of the present application, dressing materials were prepared correspondingly by the methods of the above example 2, comparative examples 1 to 7 and control group, respectively, and then an in vitro antibacterial effect test and a rat operation wound healing test were performed.
1. In vitro antibacterial effect test
The common wound strain, namely staphylococcus aureus, escherichia coli, streptococcus pyogenes and pseudomonas aeruginosa, is adopted as an experimental strain. 0.5ml of each bacterial liquid (concentration 10) 5 ～10 6 CFU/ml) was added dropwise to the blank (medical dressing without any antibacterial component added), example 2, comparative examples 1 to 7 and dressing samples of the control group, the sterilized cover sheets were held by sterilized forceps, covered on the samples, respectively, spread flat and bubble-free, the bacteria were allowed to contact the samples uniformly, placed in a sterilized plate, cultured for 24 hours at (37.+ -. 1) C and relative humidity > 90%, and then taken out, 20ml of washing solution was added, the samples and coverslips were repeatedly washed, and after sufficient shaking, the washing solution was inoculated into nutrient agar medium, and after culturing for 24 hours at (37.+ -. 1) C, viable bacteria were counted. The antibacterial rates of example 2, comparative examples 1 to 7, and the control group were calculated from the colony count of the blank group. The experimental results are shown in table 1.
Table 1 in vitro bacteriostatic effects (bacteriostatic Rate)%)
| Staphylococcus aureus | Coli bacterium | Streptococcus pyogenes | Pseudomonas aeruginosa | |
| Example 2 | 100 | 99.3 | 100 | 98.5 |
| Comparative example 1 | 98.6 | 98.2 | 97.3 | 98.0 |
| Comparative example 2 | 97.3 | 96.5 | 95.6 | 96.3 |
| Comparative example 3 | 99.3 | 96.2 | 98.1 | 97.2 |
| Comparative example 4 | 96.3 | 95.5 | 97.2 | 94.0 |
| Comparative example 5 | 83.3 | 76.6 | 82.0 | 68.3 |
| Comparative example 6 | 89.6 | 87.3 | 85.2 | 81.0 |
| Comparative example 7 | 63.6 | 65.2 | 64.2 | 70.0 |
| Control group | 85.3 | 85.3 | 84.3 | 86.0 |
As can be seen from the above table 1,
the dressing provided by the application has a good in-vitro antibacterial effect, the antibacterial rate of staphylococcus aureus, escherichia coli, streptococcus pyogenes and pseudomonas aeruginosa can reach more than 98%, the antibacterial effect is obvious, and the dressing is obviously superior to a control group, namely, the dressing prepared by the method provided by the application can effectively propagate microorganisms on wound parts all the time, and the incidence rate of wound infection is reduced.
2. Rat surgical wound healing test
90 adult healthy SD rats were anesthetized with 30mg/kg volume fraction 10% chloral hydrate by intraperitoneal injection, shaved on the back, and exposed skin. The back chest section is taken as the center, and the whole layer of skin is cut off to deep fascia according to the size of 2cm multiplied by 2cm, so that a square wound surface is formed. The post-operative animals were randomly divided into 9 groups, each corresponding to example 2, comparative examples 1 to 7, and control group, 10, and dressing corresponding to the group was used for dressing. Dressing corresponding to the group was changed daily after the operation, wound appearance was observed and recorded, wound length and width were measured at 4,7,11,14,21 th day after the operation, wound area and wound healing rate were calculated, wound healing rate= (initial wound area-wound area measured at n-th day)/initial wound area×100%, and experimental results are shown in table 2.
Table 2 healing promoting effect of each set of dressing on rat surgical wounds
The second 2 shows that the dressing prepared by the method has obvious healing promoting effect on rat operation wounds, tender and effective tissue adhesion and wound crusting prevention, the secretion absorption and drug release antibacterial effect of the dressing are separated, mutual interference is avoided, the healing rate of wounds after two weeks treatment can reach more than 98, and the wound is clean and safe and has no infection through observation.
Claims (6)
1. The preparation method of the wound antibacterial healing-promoting dressing is characterized by comprising the following steps of:
s1, preparing medicinal powder:
s101, placing natural indigo, borax and gentian together in a bead mill according to a weight ratio of 1:7-10:10-12, adding liquid nitrogen for grinding, and taking out powder A for standby after finishing;
s102, placing the powder A obtained in the step S101 into a corona discharge instrument for corona treatment, and then placing into a superfine pulverizer for pulverization treatment to obtain medicinal powder;
s2, preparing drug-loaded fibers:
s201, uniformly stirring and mixing a polyvinyl alcohol solution and a sodium alginate solution according to the weight ratio of 3-4:1 under the constant temperature condition to obtain a mixed solution A for standby;
s202, adding the medicinal powder obtained in the step S1 into the mixed solution A, and then placing the mixed solution A into a micro-jet high-pressure homogenizer for high-pressure homogenization treatment to obtain a mixed solution B for later use;
s203, spinning the mixed solution B obtained in the step S202 to obtain a drug-loaded fiber for later use;
s3, preparing secretion absorbing fibers:
adding poly-N-vinyl caprolactam and graphene oxide into the melt spinning of nylon to prepare a secretion absorbing fiber for later use;
s4, spinning:
spinning the obtained medicine carrying fiber and secretion absorbing fiber in a warp-weft spinning mode to obtain blended gauze for standby;
s5, spraying:
one side of the blended gauze is sprayed with hydrogel taking poly-N-vinyl caprolactam and graphene oxide as matrix materials.
2. The method for preparing a wound antibacterial healing-promoting dressing according to claim 1, wherein the grinding speed is controlled to be 300-400 rpm during the grinding treatment in the step S101, and the grinding treatment time is 30-40 rpm.
3. The method for preparing a wound antibacterial healing-promoting dressing according to claim 1, wherein the operating voltage is controlled to be 10-12 kV during the corona treatment in the step S102, and the time of the corona treatment is 30-40S.
4. The method for preparing a wound antibacterial healing-promoting dressing according to claim 1, wherein the constant temperature in the step S201 is 60-70 ℃.
5. The method for preparing a wound antibacterial healing-promoting dressing according to claim 1, wherein the working pressure is controlled to be 70-80 MPa during the high-pressure homogenization treatment in the step S202, and the homogenization treatment time is 40-60S.
6. A wound bacteriostatic healing-promoting dressing, characterized by being prepared by the method of any one of the above claims 1-5.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210758005.5A CN114984293B (en) | 2022-06-29 | 2022-06-29 | Wound antibacterial healing-promoting dressing and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210758005.5A CN114984293B (en) | 2022-06-29 | 2022-06-29 | Wound antibacterial healing-promoting dressing and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN114984293A CN114984293A (en) | 2022-09-02 |
| CN114984293B true CN114984293B (en) | 2023-10-17 |
Family
ID=83020725
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202210758005.5A Active CN114984293B (en) | 2022-06-29 | 2022-06-29 | Wound antibacterial healing-promoting dressing and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114984293B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN119857164B (en) * | 2025-01-13 | 2025-07-25 | 天津康卫启新科技有限公司 | A high moisture absorption and high moisture retention medical dressing capable of carrying medicine and a preparation method thereof |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0311448D0 (en) * | 2003-05-19 | 2003-06-25 | Adv Med Solutions Ltd | Absorbent material |
| CN103861144A (en) * | 2014-04-04 | 2014-06-18 | 杭州天诚药业有限公司 | Medical dressing for promoting wound healing and preparation method thereof |
| WO2019011000A1 (en) * | 2017-07-11 | 2019-01-17 | 佛山市优特医疗科技有限公司 | Reinforced wound dressing and preparation method therefor |
| CN109224116A (en) * | 2018-09-01 | 2019-01-18 | 成都市水泷头化工科技有限公司 | A kind of the antibacterial anti hemorrhagic medical dressing and preparation method of high-absorbable |
| CN110025598A (en) * | 2019-04-18 | 2019-07-19 | 山东理工大学 | A kind of crosslinking load medicine polyvinyl alcohol/sodium alginate composite nano-fiber membrane preparation with slow-release function |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7385101B2 (en) * | 2001-12-20 | 2008-06-10 | Noble Fiber Technologies, Llc | Antibiotic textile materials suitable for wound dressings and wound dressings incorporating the same |
-
2022
- 2022-06-29 CN CN202210758005.5A patent/CN114984293B/en active Active
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0311448D0 (en) * | 2003-05-19 | 2003-06-25 | Adv Med Solutions Ltd | Absorbent material |
| CN103861144A (en) * | 2014-04-04 | 2014-06-18 | 杭州天诚药业有限公司 | Medical dressing for promoting wound healing and preparation method thereof |
| WO2019011000A1 (en) * | 2017-07-11 | 2019-01-17 | 佛山市优特医疗科技有限公司 | Reinforced wound dressing and preparation method therefor |
| CN109224116A (en) * | 2018-09-01 | 2019-01-18 | 成都市水泷头化工科技有限公司 | A kind of the antibacterial anti hemorrhagic medical dressing and preparation method of high-absorbable |
| CN110025598A (en) * | 2019-04-18 | 2019-07-19 | 山东理工大学 | A kind of crosslinking load medicine polyvinyl alcohol/sodium alginate composite nano-fiber membrane preparation with slow-release function |
Also Published As
| Publication number | Publication date |
|---|---|
| CN114984293A (en) | 2022-09-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Tang et al. | Honey loaded alginate/PVA nanofibrous membrane as potential bioactive wound dressing | |
| Dong et al. | In situ deposition of a personalized nanofibrous dressing via a handy electrospinning device for skin wound care | |
| Li et al. | Electrospun scaffold of collagen and polycaprolactone containing ZnO quantum dots for skin wound regeneration | |
| WO2019091150A1 (en) | Alginate wound repair dressing and preparation method thereof | |
| CN109248333B (en) | Medical dressing for resisting bacteria and promoting wound healing and preparation method and application thereof | |
| CN104189942A (en) | Antibacterial wound dressing and preparation method thereof | |
| CN113529419B (en) | Bacterial cellulose microfiber-alginic acid fiber composite material loaded with nano zinc oxide | |
| Ma et al. | Fabrication of bioactive glass-introduced nanofibrous membranes with multifunctions for potential wound dressing | |
| CN114984293B (en) | Wound antibacterial healing-promoting dressing and preparation method thereof | |
| Sadeghi et al. | Matrix–drug interactions for the development of pH-sensitive alginate-based nanofibers as an advanced wound dressing | |
| Li et al. | Sandwich structure Aloin-PVP/Aloin-PVP-PLA/PLA as a wound dressing to accelerate wound healing | |
| CN110152049B (en) | Application of chitosan-based nanofiber membrane of medical wound dressing | |
| CN105944134A (en) | Method for preparing antibacterial wound dressing with high chitosan content by means of electrostatic spinning | |
| CN114685823B (en) | Anti-curling chitosan hydrogel film, preparation method thereof and chronic wound dressing | |
| Nazir et al. | Natural plant extract-treated bioactive textiles for wound healing | |
| CA3091141A1 (en) | Silica fiber compositions and methods of use | |
| Morad et al. | Producing Ofloxacin Loaded Gum Tragacanth/Bassorin Electrospun Nano Fibers and Evaluation Its Antibacterial Activity. | |
| CN105862251A (en) | Biomedical electrospun membrane using medical polymer materials | |
| CN109432483B (en) | Medical dressing for accelerating wound healing and preparation method and application thereof | |
| CN109381736A (en) | A kind of biodegradable medical dressing | |
| CN113481621A (en) | Wound hemostasis composite material, preparation method and application thereof | |
| Nayeb et al. | Production of wound dressing with nano fibers contain bassorin/ofloxacin for improvement burn wound | |
| JP4263871B2 (en) | Wound dressing and method for producing the same | |
| CN112587712B (en) | Composite bacterial cellulose dressing based on controllable nanofiber space structure and preparation method | |
| CN119925668B (en) | Dressing with repairing function and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |